课题基金 / 基金详情

Molecular mechanisms that specify the cardiac cell lineage

Molecular mechanisms that specify the cardiac cell lineage
指定心肌细胞谱系的分子机制
批准号:
15590738
负责人:
TANAKA Makoto
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

TANAKA Makoto的其他基金

相似基金

相关文献

中文摘要
翻译
在这项研究中,我们通过分析Nkx2.5(一种心脏特异性转录因子)的增强子,研究了指定心脏细胞谱系的分子机制。我们分离了覆盖60kb Nkx2.5上游序列的BAC克隆,并生成了大约70个包含不同长度上游序列的报告基因构建。我们测量了大鼠新生心肌原代培养中每个结构体的荧光素酶活性,并确定了6个荧光素酶活性显著高的区域。我们将这6个DNA片段亚克隆到LacZ报告载体中,并产生了转基因小鼠。6个片段中有3个片段在体内表现出增强子活性。特别是,Nkx2.5上游5.2 - 6.4kb的DNA片段在从心新月到直心管的心肌细胞中表现出很强的活性。该DNA片段含有串联Smad结合位点,Smad结合位点的缺失几乎消除了培养心肌细胞中的增强子活性。这一结果表明,在心脏发育的早期阶段,Smad信号通路是Nkx2.5表达所必需的,并且可能在心脏细胞谱系的规范中起关键作用。我们现在正试图用转基因方法在体内证实这一结果。在这个片段中,我们还发现了另一个具有高报告活性的区域。由于该区域不含已知的顺式作用元件,我们尝试用酵母单杂交系统分离结合蛋白。
英文摘要
In this study, we investigated molecular mechanisms that specify the cardiac cell lineage by analyzing enhancers of Nkx2.5, a cardiac specific transcription factor. We isolated BAC clones that cover 60kb of upstream sequence of Nkx2.5 and generated approximately 70 reporter constructs containing various length of the upstream sequence. We measured luciferase activity of each construct in primary culture of rat neonatal cardiac myoctyes and identified 6 regions exhibiting significantly high luciferase activities. We subcloned these 6 DNA fragments into a LacZ reporter vector and generated transgenic mice. Out of the 6 fragments, 3 fragments showed enhancer activities in vivo. Particularly, a DNA fragment between 5.2 and 6.4kb upstream of Nkx2.5 exhibited strong activity in cardiac myocytes from the cardiac crescent to the straight heart tube. This DNA fragment contained tandem Smad binding sites and deletion of the Smad binding sites almost abolished the enhancer activity in cultured cardiac myocytes. This result suggested that the Smad signaling pathway was required for expression of Nkx2.5 at early stages of cardiac development and may play a critical role in the specification of the cardiac cell lineage. We are now trying to confirm this result in vivo using transgenic approach. In this fragment, we also found another region having high reporter activity in vitro. Since this region did not contain known cis-acting elements, we are trying to isolate binding proteins using yeast one-hybrid system.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
Up-regulation of SR-PSOX/CXCL16 and recruitment of CD8^+ T cells in cardiac valves during inflammatory valvular heart disease.
炎症性瓣膜性心脏病期间心脏瓣膜中 SR-PSOX/CXCL16 的上调和 CD8^T 细胞的募集。
DOI: --
发表时间: 2004
期刊: Arterioscler.Thromb.Vase.Biol. 24
影响因子: --
作者: [Zhuge X, Murayama T, Arai H, Yamauchi R, Tanaka M, Shimaoka T, Yonehara S, Kume N, Yokode M, Kita T, Ryoko Yamauchi]
通讯作者: Ryoko Yamauchi
Critical roles of CXC chemokine ligand 16/SR-PSOX in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis.
CXC 趋化因子配体 16/SR-PSOX 在急性和过继转移实验性自身免疫性脑脊髓炎发病机制中的关键作用。
DOI: --
发表时间: 2004
期刊: J.Immunol. 173
影响因子: --
作者: [Fukumoto N, Shimaoka T, Fujimura H, Sakoda S, Tanaka M, Kita T, Yonehara S]
通讯作者: Yonehara S
Ryoko Yamauchi: "Up-regulation of SR-PSOX/CXCL16 and recruitment of CD8^+ T cells in cardiac valves during inflammatory valvular heart disease"Arterioscler Thromb Vasc Biol. 24. 282-287 (2004)
Ryoko Yamauchi:“炎症性瓣膜性心脏病期间心脏瓣膜中 SR-PSOX/CXCL16 的上调和 CD8+T 细胞的募集”Arterioscler Thromb Vasc Biol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1128/mcb.24.11.4627-4635.2004
发表时间: 2004-06-01
期刊: MOLECULAR AND CELLULAR BIOLOGY
影响因子: 5.3
作者: [Togi, K, Kawamoto, T, Tanaka, M]
通讯作者: Tanaka, M
9
    Examination of the infuluence of zinc on the expression of taste receptor genes(T1Rs) in the rat tongue
    • 批准号:
      26861422
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.91万
    • 财政年份:
      2014
    • 负责人:
      TANAKA Makoto
    • 依托单位:
    Strategic banking under imperfect competition: Dynamic analysis of emissions permit and power banking
    Establishment of treatment method by whole body administration of gene modification BM-MSC in acute lung injury
    • 批准号:
      25670610
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2013
    • 负责人:
      TANAKA Makoto
    • 依托单位:
    Development of a patient orientated self-management approach for people with inflammatory bowel disease: a preliminary study
    • 批准号:
      22792175
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2010
    • 负责人:
      TANAKA Makoto
    • 依托单位:
    国内基金
    海外基金
    损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
    • 批准号:
      82371721
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      王星云
    • 依托单位:
    增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
    • 批准号:
      82371668
    • 项目类别:
      面上项目
    • 资助金额:
      52.00万元
    • 批准年份:
      2023
    • 负责人:
      乔云波
    • 依托单位:
    MAP2的m6A甲基化在七氟烷引起SST神经元树突发育异常及精细运动损伤中的作用机制研究
    • 批准号:
      82371276
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      严佳
    • 依托单位:
    "胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
    • 批准号:
      82372327
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      马展
    • 依托单位: